EME -A Phase II Randomised Clinical Trial of Conditioning Cyclophosphamide and Chemoembiolisation with or without Vaccination with Dendritic Cells Pulsed with HepG2 Lysate in vivo in Patients with Hepatocellular Carcinoma : IMMUNOTACE Trial

Short title	EME -A Phase II Randomised Clinical Trial of Conditioning Cyclophosphamide and Chemoembiolisation with or without Vaccination with Dendritic Cells Pulsed with HepG2 Lysate in vivo in Patients with Hepatocellular Carcinoma : IMMUNOTACE Trial
Status	Finished
Effective start/end date	1/01/13 → 31/07/21

Project Details